OMX Nordic 40
| 
					
 2 365,32 					
				 | 
				
					
 -10,28 					
				 | 
				
					
 -0,43 % 					
				 | 
				
Analysen zu OMX Nordic 40-Werten
| 27.11.23 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 27.11.23 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 24.11.23 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 24.11.23 | ABB Neutral | JP Morgan Chase & Co. | |
| 22.11.23 | Hennes & Mauritz AB Neutral | UBS AG | |
| 21.11.23 | Hennes & Mauritz AB Neutral | UBS AG | |
| 20.11.23 | AstraZeneca Overweight | Barclays Capital | |
| 20.11.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 20.11.23 | Volvo AB Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.11.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.11.23 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 16.11.23 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 15.11.23 | Hennes & Mauritz AB Neutral | UBS AG | |
| 10.11.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 09.11.23 | ABB Buy | Goldman Sachs Group Inc. | |
| 08.11.23 | A.P. Moeller - Maersk A-S Overweight | JP Morgan Chase & Co. | |
| 07.11.23 | ABB Buy | Goldman Sachs Group Inc. | |
| 07.11.23 | AstraZeneca Hold | Deutsche Bank AG |